Baker Bros. Advisors’s Cellectis CLLS Stock Holding History

Baker Bros. Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-50,000	Closed	-$1.42M	–	102
2018 Q2	$1.42M	Hold	50,000	–	–	0.01%	99
2018 Q1	$1.58M	Hold	50,000	–	–	0.01%	94
2017 Q4	$1.46M	Hold	50,000	–	–	0.01%	102
2017 Q3	$1.42M	Hold	50,000	–	–	0.01%	103
2017 Q2	$1.29M	Hold	50,000	–	–	0.01%	98
2017 Q1	$1.2M	Hold	50,000	–	–	0.01%	98
2016 Q4	$848K	Hold	50,000	–	–	0.01%	111
2016 Q3	$1.2M	Hold	50,000	–	–	0.01%	105
2016 Q2	$1.33M	Hold	50,000	–	–	0.01%	111
2016 Q1	$1.38M	Hold	50,000	–	–	0.01%	110
2015 Q4	$1.55M	Hold	50,000	–	–	0.01%	112
2015 Q3	$1.32M	Hold	50,000	–	–	0.01%	113
2015 Q2	$1.8M	Hold	50,000	–	–	0.02%	106
2015 Q1	$1.73M	Buy	+50,000	New	+$1.81M	0.01%	110

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Baker Bros. Advisors's CLLS Position: Q3 2018 in Review

Baker Bros. Advisors sold out of Cellectis (CLLS) in Q3 2018, closing a stake of 50,000 shares — an estimated $1.42M sold.

Baker Bros. Advisors first reported a position in CLLS in Q1 2015 and held it in 14 quarters. The position peaked at $1.8M in Q2 2015. 81 funds tracked by Wall St. Rank hold CLLS as of Q3 2018.

Baker Bros. Advisors reported no remaining Cellectis position as of Q3 2018 after selling out during the quarter.
Baker Bros. Advisors sold 50,000 Cellectis shares in Q3 2018, an estimated $1.42M.
Baker Bros. Advisors first reported a position in Cellectis in Q1 2015 and held it in 14 quarters.
Baker Bros. Advisors's Cellectis position peaked at $1.8M in Q2 2015.
81 funds tracked by Wall St. Rank held Cellectis as of Q3 2018.

Based on Baker Bros. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.